Your browser doesn't support javascript.
loading
Cost-Effectiveness of Pazopanib Versus Sunitinib for Renal Cancer in the United States.
Benedict, Agnes; Ramaswamy, Krishnan; Sandin, Rickard.
Affiliation
  • Benedict A; Evidera. agnes.benedict@evidera.com.
J Manag Care Spec Pharm ; 21(9): 834-40, 2015 Sep.
Article in En | MEDLINE | ID: mdl-26308230
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyrimidines / Pyrroles / Sulfonamides / Carcinoma, Renal Cell / Cost-Benefit Analysis / Indoles / Kidney Neoplasms Type of study: Guideline / Health_economic_evaluation Limits: Female / Humans / Male Language: En Journal: J Manag Care Spec Pharm Year: 2015 Document type: Article Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyrimidines / Pyrroles / Sulfonamides / Carcinoma, Renal Cell / Cost-Benefit Analysis / Indoles / Kidney Neoplasms Type of study: Guideline / Health_economic_evaluation Limits: Female / Humans / Male Language: En Journal: J Manag Care Spec Pharm Year: 2015 Document type: Article Country of publication: